Skip to main content
. 2021 Feb 10;10(2):270. doi: 10.3390/antiox10020270

Figure 1.

Figure 1

Interplay between liver and body targets in non-alcoholic fatty liver disease (NAFLD)/metabolic associated fatty liver disease (MAFLD).